Literature DB >> 19184547

Isolation and characterization of low molecular weight glycosaminoglycans from marine mollusc Amussium pleuronectus (linne) using chromatography.

R Saravanan1, A Shanmugam.   

Abstract

The glycosaminoglycan (GAG) heparin is a polyanionic sulfated polysaccharide most recognized for its anticoagulant activity. In the present study, the GAGs were extracted from bivalve mollusc Amussium pleuronectus. The crude GAGs were fractionated by ion-exchange (DEAE-cellulose and Amberlite IRA-900 & 120) chromatography. The recovered active fractions (as determined by metachromatic assay) were confirmed by agarose gel electrophoresis and the active fractions were purified in Sephadex G-100 column. Fractionated and purified GAG molecular weight was determined through gradient polyacrylamide gel electrophoresis. The structural characterization of low molecular weight GAG was analyzed by Fourier transform infrared spectroscopy. The activated partial thromboplastin time of purified GAG is 95 IU/mg and has molecular weight 6,500-7,500 Da. The disaccharide compositional analysis on the GAG sample was sulfated like porcine intestinal mucosal heparan sulfate, and it contains equivalent amount of uronic acid and hexosamine. The results of this study suggest that the GAG from A. pleuronectus could be an alternative source of heparin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184547     DOI: 10.1007/s12010-008-8498-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  3 in total

1.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 2.  Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering.

Authors:  Karim Senni; Jessica Pereira; Farida Gueniche; Christine Delbarre-Ladrat; Corinne Sinquin; Jacqueline Ratiskol; Gaston Godeau; Anne-Marie Fischer; Dominique Helley; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2011-09-23       Impact factor: 6.085

Review 3.  Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.

Authors:  Fahad Akhtar; Xinyu Wan; Gang Wu; Samuel Kesse; Shaoda Wang; Shuying He
Journal:  Molecules       Date:  2018-07-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.